Research Feeds

View All
Characterizing the gut microbiota in females with infertility and preliminary results of a water-soluble dietary fiber intervention study A prebiotic dietary pilot intervention restores faecal metabolites and may be neuroprotective in Parkinson’s Disease Diagnosis of the menopause: NICE guidance and quality standards Causes of Death in End-Stage Kidney Disease: Comparison Between the United States Renal Data System and a Large Integrated Health Care System Factors affecting the absorption and excretion of lead in the rat Factors associated with age at menarche, menstrual knowledge, and hygiene practices among schoolgirls in Sharjah, UAE Cadmium transport in blood serum The non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic Structured Exercise Benefits in Euthyroid Graves’ Disease: Improved Capacity, Fatigue, and Relapse Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease A Pilot Microbiota Study in Parkinson’s Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models Dysbiosis of the Saliva Microbiome in Patients With Polycystic Ovary Syndrome Integrated Microbiome and Host Transcriptome Profiles Link Parkinson’s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain Gut microbiota modulation: a narrative review on a novel strategy for prevention and alleviation of ovarian aging Long-term postmenopausal hormone therapy and endometrial cancer

Posts tagged with "Gut microbiota" (A-Z)

C
Characterizing the gut microbiota in females with infertility and preliminary results of a water-soluble dietary fiber intervention study
A
Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder
G
Gut Microbiota is Altered in Patients with Alzheimer’s Disease
Gut microbiota in patients with Parkinson’s disease in southern China
Gut Microbiota and Metabolome Alterations Associated with Parkinson’s Disease
D
Differences in gut microbiota structure in patients with stages 4-5 chronic kidney disease
A
An analysis of the characteristics of the intestinal flora in patients with Parkinson’s disease complicated with constipation
C
Changes in the Gut Microbiota of Children with Autism Spectrum Disorder
G
Gut metagenomics-derived genes as potential biomarkers of Parkinson’s disease
C
Clinical Phenotypes of Parkinson’s Disease Associate with Distinct Gut Microbiota and Metabolome Enterotypes
Characteristics of the Gut Microbiota in Japanese Patients with Premenstrual Syndrome
G
Graves’ Disease Gut Microbiome Signatures: Key Genera and Clinical Implications
E
Effects of Glucagon-Like Peptide-1 Receptor Agonists on Gut Microbiota in Dehydroepiandrosterone-Induced Polycystic Ovary Syndrome Mice: Compared Evaluation of Liraglutide and Semaglutide Intervention
A
Altered Gut Microbiota in Chinese Children With Autism Spectrum Disorders
Alterations to the Gut Microbiota and Their Correlation With Inflammatory Factors in Chronic Kidney Disease
I
Imbalance in the Gut Microbiota of Children With Autism Spectrum Disorders
G
Graves’ Disease Gut Microbiota: Distinct Microbial Signatures and Clinical Associations
A
Alteration in gut microbiota is associated with immune imbalance in Graves’ disease
C
Correlation Between Fecal Metabolomics and Gut Microbiota in Obesity and Polycystic Ovary Syndrome
D
Diversity of the Gut Microbiota in Dihydrotestosterone-Induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine
A
Alteration of the gut microbiota profile in children with autism spectrum disorder in China
N
Nutritional Intake and Gut Microbiome Composition Predict Parkinson’s Disease
E
Exploring the alteration of gut microbiota and brain function in gender-specific Parkinson’s disease based on metagenomic sequencing
F
Fecal Microbiota Changes in Patients With Postpartum Depressive Disorder
G
Gut Microbiota Differs Between Parkinson’s Disease Patients and Healthy Controls in Northeast China
I
Irisin alleviated the reproductive endocrinal disorders of PCOS mice accompanied by changes in gut microbiota and metabolomic characteristics
M
Molecular Alteration Analysis of Human Gut Microbial Composition in Graves’ disease Patients
A
Alteration of the fecal microbiota in Chinese patients with Parkinson’s disease
G
Gut microbiota in Parkinson disease in a northern German cohort
S
Systematic analysis of gut microbiome reveals the role of bacterial folate and homocysteine metabolism in Parkinson’s disease
G
Gut microbiota in Parkinson’s disease: Temporal stability and relations to disease progression
M
Metagenomic analysis identified microbiome alterations and pathological association between intestinal microbiota and polycystic ovary syndrome
G
Gut microbiota changes in patients with autism spectrum disorders
A
Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly
S
Short chain fatty acids and gut microbiota differ between patients with Parkinson’s disease and age-matched controls
D
Dysbiosis of gut microbiota in a selected population of Parkinson’s patients
A
Altered gut microbiota in Parkinson’s disease patients with motor complications
Altered gut microbiota and microbial biomarkers associated with chronic kidney disease
C
Correlations between serum cytokines and gut microbiota in patients with Graves’ disease: A case-control study
S
Stratification of the Gut Microbiota Composition Landscape across the Alzheimer’s Disease Continuum in a Turkish Cohort
Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson’s Disease but Not in Rapid-Eye-Movement Sleep Behavior Disorder
G
Gut and oral microbial compositional differences in women with breast cancer, women with ductal carcinoma in situ, and healthy women
M
Metagenomic Characterization of Gut Microbiota in Children with Autism Spectrum Disorder: Microbial Signatures and Modulation by Anti-Inflammatory Diet and Probiotics
G
Gut Microbiome Signatures in Graves’ and Hashimoto’s Disease: Microbial Markers and ABC Transporter Pathway Insights
D
Dysbiosis of the Beneficial Gut Bacteria in Patients with Parkinson’s Disease from India
T
The Gut Microbiome in Parkinson’s Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies
M
Multi-omics analyses reveal the specific changes in gut metagenome and serum metabolome of patients with polycystic ovary syndrome
A
Analysis of Gut Microbiota in Patients with Parkinson’s Disease
D
Disturbed microbial ecology in Alzheimer’s disease: evidence from the gut microbiota and fecal metabolome
A
Association between premature ovarian insufficiency and gut microbiota
G
Gut microbiome in patients with early-stage and late-stage endometriosis
E
Evaluation of fecal microbiota transplantation in Parkinson’s disease patients with constipation
I
Injection of amyloid-β to lateral ventricle induces gut microbiota dysbiosis in association with inhibition of cholinergic anti-inflammatory pathways in Alzheimer’s disease
Q
Quinoa ameliorates polycystic ovary syndrome via regulating gut microbiota through PI3K/AKT/mTOR pathway and autophagy
T
The gut microbial composition in polycystic ovary syndrome with insulin resistance: findings from a normal-weight population
I
Integrated fecal microbiota and metabolomics analysis of the orlistat intervention effect on polycystic ovary syndrome rats induced by letrozole combined with a high-fat diet
E
Effects of gut microbiota on omega-3-mediated ovary and metabolic benefits in polycystic ovary syndrome mice
A
Altered gut microbiota in patients with idiopathic Parkinson’s disease: an age-sex matched case-control study
E
Effects of inulin on intestinal flora and metabolism-related indicators in obese polycystic ovary syndrome patients
N
New evidences on the altered gut microbiota in autism spectrum disorders
B
Breast cancer in postmenopausal women is associated with an altered gut metagenome
A
Androgen-induced gut dysbiosis disrupts glucolipid metabolism and endocrinal functions in polycystic ovary syndrome
G
Gut Microbiota in Graves’ Disease and Graves’ Orbitopathy: Distinct Microbial Signatures and Implications
Gut Microbiota Signatures in Graves’ Disease: Key Associations and Biomarker Potential
D
Dietary composition modulate gut microbiota and related biomarkers in patients with chronic kidney disease
E
Exploring the Relevance between Gut Microbiota-Metabolites Profile and Chronic Kidney Disease with Distinct Pathogenic Factor
D
Dysbiotic alteration in the fecal microbiota of patients with polycystic ovary syndrome
A
Alterations of the Gut Microbiota in Hashimoto’s Thyroiditis Patients
G
Graves’ Disease Gut Microbiome Signature: Diagnostic and Pathogenic Insights
A
A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?
Alterations in Gut Microbial Communities Across Anatomical Locations in Inflammatory Bowel Diseases
Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data
Associations Between Endometriosis and Gut Microbiota
G
Gastrointestinal Dysmotility Predisposes to Colitis through Regulation of Gut Microbial Composition and Linoleic Acid Metabolism
Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome
Gut microbiota imbalance and its correlations with hormone and inflammatory factors in patients with stage 3/4 endometriosis
Gut microbiota in early pediatric multiple sclerosis: a case-control study
M
Molecular estimation of alteration in intestinal microbial composition in Hashimoto’s thyroiditis patients
S
Self-Balance of Intestinal Flora in Spouses of Patients With Rheumatoid Arthritis
Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.